Obesity

Though the association of BMI gain and 100% fruit juice in children was “small,” authors concluded their findings support public health guidance to limit consumption of the beverage to prevent overweight and obesity.

The United States Preventive Services Task Force (USPSTF) is planning to recommend that comprehensive, intensive behavioral interventions be the primary effective intervention for weight loss in children and adolescents with high body mass indexes (BMI).

In a systematic and meta-analysis review of cohort studies that featured nearly 1.7 million individuals, study authors concluded that there is an association between high body mass index (BMI) and an increased risk of incident type 1 diabetes (T1D).

Data from a 4-year trial of preschool-aged children offers new insight into the effects of initiating obesity management strategies among children in early life.

To combat this association, study investigators concluded a reduction in daily soft drink consumption should be a priority among school-going adolescents.

A new scientific statement indicates lifestyle interventions may change the trajectory of obesity-related cardiovascular risk from onset in childhood to manifestation in adulthood.

GLP-1 receptor agonists, used to treat diabetes, are now also being used for obesity in children and adolescents.

An analysis of data from nearly 750,000 adolescents from more than 40 countries offers insight into the changing, and possibly inaccurate, perceptions of healthy body weight among younger people since the turn of the century.

The American Medical Association is asking doctors to scale back the use of the body mass index (BMI) when assessing obesity and health in patients, noting it should be used jointly with other measurements, and not solely. 

A new analysis found differences in the gut bacteria seen in adults with obesity, suggesting that changes in the gut microbiota that predispose to adult obesity may begin in early childhood.

Children exposed to maternal COVID-19 during pregnancy showed lower birth weight, lower birth BMI, and accelerated postnatal weight gain, compared with those unexposed.

Built environments, but not social and economic environments, were negatively associated with BMI and overweight or obesity status, with a stronger association among adolescents with longer exposure to their built environment.

In a recent study, reductions in body mass index along with further beneficial effects were found when using oral butyrate supplementation for treating pediatric obesity.

In part 1 of our obesity series, Katherine H. Saunders, MD, DABOM, discusses methods of treating pediatric obesity, including medicines approved by the FDA and the advantages of Intellihealth.

A study from Slovenia suggests a physical activity intervention that would require physical activity every day while at school was effective for reducing BMI and reversing obesity in young children.

Youth who underwent metabolic and bariatric surgery as teenagers are at heightened risk for alcohol use, according to a recent study.

A sugary drinks tax in England may have prevented over 5,000 cases of obesity a year in older girls, but had no significant association with obesity levels in year six boys or younger children.

A follow-up to a Texas Sprouts gardening intervention found improved glucose control and reduced low-density lipoprotein cholesterol in individuals at a high risk of metabolic diseases.

The February 2023 edition of Pediatrics included evidence-based guidelines from the American Academy of Pediatrics on evaluating and treating obesity in children and adolescents.

A recent study found that children were more likely to present with high BMI and obesity if they had low Child Opportunity Index scores early in life.

Using data from more than 25,000 preschool-aged children in Sweden provides an overview in trends of weight gain and BMI changes that may have impacted pediatric populations during the COVID-19 pandemic.

In a recent study, it was found that children with medical complexity are at a greater risk of overweight and obesity compared to children without medical complexity.

Novo Nordisk has announced their product Wegovy received approval from the US Food and Drug Administration for use in adolescents aged 12 years and older with obesity.

In a recent study, it was found that obesity is not present in all cases of type 2 diabetes in pediatric patients.

Amy L. Kiskaddon, PharmD, MBA, BCPPS, discusses how medication doses need to be adjusted for pediatric patients with obesity.